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Lead is a well-known environmental pollutant due to its widespread industrial uses and persistent nature. Studies have 
underlined the toxicities caused due to occupational exposure to lead and have also reported the association of blood lead 
levels (BLL) with Vitamin D Receptor (VDR) gene polymorphism; however, such data is scarce from India. This maiden 
attempt aims to investigate the association of different VDR polymorphic variants on BLL in the north-Indian lead-exposed 
population. We recruited 100 occupationally leadexposed battery workers (LEBW) and 100 non-lead exposed controls 
(NLEC). BLL, serum Vitamin D, calcium and phosphorous levels were measured. Further, VDR polymorphisms namely, 
FokI, TaqI, ApaI, and BsmI polymorphic variants were studied. Results demonstrated that BLL was significantly increased 
in LEBW as compared to NLEC. Chisquare test results show that frequencies of Ff FokI VDR genotype and bb BsmI VDR 
genotype were significantly more in LEBW as compared to NLEC (P =0.02 and 0.03, respectively). Furthermore, FF, aa and 
bb genotype showed the highest BLL in LEBW indicating higher lead levels in some VDR polymorphisms. 
Keywords: ApaI, Blood lead levels (BLL), BsmI, FokI, Occupational exposure, TaqI, Vitamin D receptor (VDR) 
polymorphism, Vitamin D 
Lead (Pb) is a ubiquitous, persistent and major 
environmental pollutant. Its omnipresent nature and 
widespread use cause millions of people to be 
exposed to lead
1
. Multiple ways of exposure including 
dermal contact, inhalation, and ingestion are involved 
in lead induced health effects2,3. Occupational 
exposure is a major contributor to exposure in 
workers engaged in industries including lead 
smelting, paints, ceramics, lead battery manufacturers, 
automobile technicians etc
4-6
. The population of lead-
exposed battery workers (LEBW) has recently 
increased considerably due to increased usage of lead 
batteries in industries like automobiles and 
electronics. In humans, lead causes a wide range of 
biological effects depending upon the levels and 
duration of exposure viz. oxidative stress
7
, cognitive 
deficits
8
, intelligence, and memory deficits, attention 
disorders
9
, anemia,immune toxicity
10
, effects on fetus 
and child growth
11
 and cardiovascular effects
12
. As 
per the report given by CDC 2011, lead poisoning 
refers to a condition when lead levels are >10 µg/dL 
in blood
13
. This has recently been further reduced to  
5 µg/dL by National Institute for Occupational Safety 
and Health (NIOSH) in 2015. 
Upon entering the body, lead distributes itself 
throughout the body and the major proportion is 
stored in bone
14,15
. Therefore, bone comprises the 
chief reservoir of lead and is mobilized to the 
circulation whenever it is needed. Pb mobilizes from 
bone to bloodstream via bone resorption which is 
similar to minerals like Ca
2+,16
. Pb and Ca
2+
 follow 
similar metabolic pathways for their toxicity.  
Multiple in vitro and in vivo studies have proved  
that these two minerals compete for similar locations 
inside the body
17,18
. Vitamin D and its active form  
(1, 25-dihydroxy vitamin D or calcitriol) play a 
significant role in absorption and regulation of 
calcium in the body. Studies are reporting that vitamin 
D by binding to its receptor (vitamin D receptor), a 
—————— 
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nuclear transcription factor, activates a large number 
of target genes including calcium binding protein 
calbindin-D which plays a crucial role in the intestinal 
absorption of calcium
19,20
. Earlier, studies have 
reported that, increased synthesis of calbindin-D 
significantly enhanced the absorption of calcium in 
the gut and ultimately its deposition in bone. 
Furthermore, VDRs are distributed in most cells in the 
body including osteoblasts, intestinal epithelial cells, 
and kidney tubular cells
21
.  
The gene for VDR is very large and localized on 
chromosome 12q13.1 and consists of one noncoding 
exon (1a - 1f) along with eight protein coding 
exons (2-9). Four among the many known  
single nucleotide polymorphisms (SNP) include 
ApaI (RS7975232), BsmI (RS1544410), TaqI 
(RS731236), and FokI (RS2228570). Multiple 
studies reported that these SNPs are associated  
with the regulation of calcium absorption in  
many diseases
22-25
. Further, a few studies have  
also emphasized the role of these SNPs in 
modulating the Pb levels in several populations
26,27
. 
Several reports also indicate an underlying potential 
role of these SNPs in regulating the circulatory 
levels of lead in exposed populations. However, 
globally only a few reports have tried to establish  
an association between VDR SNPs and BLL and  
this is a maiden effort in Indian scenario which 
attempts to show the effects of different genotypes of 
VDR on blood lead levels in occupationally exposed 
battery workers
28-31
.  
Hence in the present study, the association of VDR 
polymorphisms with the blood lead levels 
inoccupationally lead exposed battery workers was 
investigated.  
 
Materials and Methods 
 
Study Subjects 
In this cross-sectional study, 200 adult males who 
had no obvious health problems were recruited after 
clearance from the Institutional Ethical Committee 
(IEC) and written informed consent was obtained 
from all the subjects. The study had two arms: 100 
occupationally lead exposed male workers working 
in the battery industry (LEBW) and 100 age 
matched males, not occupationally exposed to lead as 
controls (NLEC), recruited from the Delhi-NCR 
region of India. On recruitment, anthropometric 
measurements were recorded, and all participants 
were asked to complete a questionnaire having 
questions related to demographic characteristics, 
duration of employment, smoking status, alcohol 
consumption, food preferences (vegetarian and non-
vegetarian) and current illness. Subjects who reported 
any medical disorders or were found to have any 
obvious medical conditions from clinical history and 
examinations and those on any medications 
continuing for more than a week were excluded from 
the study. 
 
Clinical laboratory analysis 
5 mL of the venous blood sample was collected 
from all participants. From the total of 5 mL blood 
taken for study, 2.0 mL of whole blood was stored in 
EDTA vial at −80°C for blood lead levels estimation 
until analysis. Again 2.0 mL of whole blood taken in 
the plain vial was used for the serum separation by 
centrifugation at 3000 rpm at 4°C for 10min and then 
stored at −20°C for estimation of various clinical 
parameters including serum vitamin D, calcium, 
phosphorous. Rest 1.0 mL of whole blood taken in 
EDTA vial was used for DNA isolation. Routine 
biochemistry parameters including serum calcium and 
phosphorous were measured using a Modular P 
biochemistry auto-analyzer (Roche diagnostic, 
Indianapolis, IN). 
 
Blood lead levels (BLL) estimation 
Whole blood lead levels were measured using an 
inductively coupled plasma optical emission 
spectrometer (ICP-OES) (Optima 8000, Perkin Elmer, 
Waltham, MA). Briefly, 2.0 mL whole blood was 
digested in the presence of 2.0 mL nitric acid and  
0.2 mL hydrogen peroxide at specified power, 
temperature and duration of time in Microwave 
Digestive System 3000 (Anton Paar, Graz, Austria) 
(Table 1). Digested samples were made up to 5 mL 
with triple distilled water and analyzed in ICP-OES 
machine along with known standards having defined 
concentration. 
 
Enzyme linked immune sorbent assay (ELISA) 
Estimation of serum total Vit D was done using 
Vitamin D ELISA kit (Cal Biotech, El Cajon, CA). 
The principle of detection was a competitive binding 
detection method and was performed as per 
manufacturer’s instruction.  
Table 1 — Operating conditions for the microwave digestion system 
S. No. Power (W) Ramp (min) Hold (min) Fan 
1 400 5 10 1 
2 800 5 10 1 
3 0 0 10 3 
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Genotyping 
Genomic DNA was extracted from whole blood 
using commercially available kits (Qiagen, Hilden, 
Germany). DNA quality and quantity were determined 
using NanoDrop 1000 UV-Vis spectrophotometer 
(Thermo Fisher Scientific Inc., USA). VDR gene 
polymorphisms (FokI, TaqI, ApaI, and BsmI) were 
studied using polymerase chain reaction followed by 
restriction fragment length polymorphism (PCR-RFLP). 
Primers were commercially synthesized and procured 
from Eurofins MWG Operon (Germany). The sequence 
of forward and reverse primers for all studied VDR 
polymorphic variants is given in (Table 2). For 
restriction digestion, all FokI, TaqI, ApaI, and BsmI 
primer-specific amplicons were digested by incubating 
with their respective restriction enzymes and separation 
was done on 2% agarose gel electrophoresis. Staining 
was done using EtBr and the image was captured on a 
gel documentation system (Protein Simple, San Jose, 
California). 
 
Statistical analysis  
Results were analyzed statistically using GraphPad 
Prism 6 and SPSS version 21.0. Data were expressed as 
mean, median (range) for study subjects. Independent  
t-test (for parametric data) and Mann-Whitney U test 
(for nonparametric data) were used to compare the 
available data. Chi-square analysis was used to check for 
the distribution of genotypes (Hardy–Weinberg 
equilibrium) and alleles. Regression analysis was used to 
determine the association between BLL and VDR SNPs 
along with other clinical parameters. Statistical 
significance was defined at a P <0.05. 
 
Results 
The demographic data of the recruited subjects 
have been published in our previous study
32
. The 
mean duration of exposure for LEBW was 14.8 ± 9.5 
years. Results detailing the genotypic and allelic 
frequency of FokI, TaqI, BsmI, and ApaI variants of 
the VDR gene are given in (Table 3). Results 
Table 2 — Forward and reverse primers sequence 
Name of 
the gene 
Primers Primer sequences 
Amplicon size; 
Annealing 
temperature (C) 
FokI 
FP 
5-AGCTGGCCCT 
GGCACTGACTC 
TGCTCT-3 269 bp; 
58C 
RP 
5- ATGGAAACAC 
CTTGCTTCTTCT 
CCCTC-3 
TaqI & 
ApaI 
FP 
5-CAACCAAGAC 
TACAAGTACCG 
CGTCAGTGA-3 2000 bp; 
63C 
RP 
5-CACTTCGAGC 
ACAAGGGGCG 
TTAGC-3 
BsmI 
FP 
5-CAACCAAGAC 
TACAAGTACCG 
CGTCAGTGA-3 825bp; 
58C 
RP 
5-AACCAGCGGG 
AAGAGGTCAA 
GGG-3 
Table3 — Prevalence of VDR polymorphisms (FokI, TaqI, ApaI and BsmI) in occupationally lead exposed battery workers (LEBW) and 
occupationally non-exposed controls (NLEC) 
Genotype Genotype frequency 
HWE P -value 
Allele frequency 
 NLEC (100) LEBW (100) NLEC LEBW 
Fok1  F f F f 
FF 69 49 
0.02* 0.83 0.17 0.73 0.28 Ff 28 47 
ff 3 4 
Taq1  T t T t 
TT 48 48 
0.99 0.70 0.31 0.70 0.31 Tt 43 43 
tt 9 9 
Apa1  A a A a 
AA 37 32 
0.50 0.56 0.45 0.50 0.51 Aa 37 35 
aa 26 33 
Bsm1  B b B b 
BB 35 21 
0.03* 0.57 0.44 0.43 0.58 Bb 43 43 
bb 22 36 
*P <0.05. Chi square test was used to determine the genotypic difference. 
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demonstrate that allelic frequencies of wild type FokI 
F allele and mutant f allele were 0.73% and 0.28% in 
LEBW while in NLEC, it was observed to be 0.83% 
and 0.17% implicating that allelic frequency of f was 
significantly higher among the LEBW. Genotypic 
frequencies of FokI FF and Ff genotype were 0.49% 
and 0.47%, respectively, in LEBW and 0.69% and 
0.28%, respectively, in NLEC, whereas, the frequency 
of ff genotype was 0.04% in LEBW and 0.03% in 
NLEC. Chisquare test results concluded that Ff 
genotype was significantly associated with LEBW 
compared to NLEC. 
Further, allelic frequencies of wild type TaqI T 
allele and mutant t allele were 0.70% and 0.31%, 
respectively, in LEBW and in NLEC it was 0.70% 
and 0.31%, respectively. Genotypic frequencies of 
TaqI TT and Tt genotypes were 0.48% and 0.43%, 
respectively, in LEBW and 0.48% and 0.43%, 
respectively, in NLEC, whereas, the frequency of tt 
genotype was 0.09% in battery workers and 0.09% in 
controls. Chi square test showed no significant 
association of TaqI polymorphisms in LEBW 
compared to NLEC.  
Similarly, allelic frequencies of wild type ApaI A 
allele and mutant a alleles were 0.50% and 0.51%, 
respectively, in LEBW and 0.56% and 0.45%, 
respectively, in NLEC. The genotypic frequencies of 
ApaI AA and Aa genotypes were 0.32% and 0.35%, 
respectively, in LEBW and 0.37% and 0.37%, 
respectively, in NLEC groups. The frequencies of aa 
genotypes were 0.33% in battery workers and 0.26% 
in controls. ChiSquare test revealed no significant 
association of ApaI polymorphism with LEBW. 
Lastly, allelic frequencies of wild-types BsmI B 
allele and mutant b allele were 0.43% and 0.58%, 
respectively, in LEBW and NLEC they were 0.57% 
and 0.44%, respectively. Genotypic frequencies  
of BsmI BB and Bb genotypes were found to be 
0.21% and 0.43%, respectively, in battery workers 
and 0.35% and 0.43% in controls, whereas, 
frequencies of bb genotype were 0.36% in battery 
workers and 0.22% in controls. Chi square test 
demonstrated a statistically significant increase in  
the bb genotype frequency in LEBW compared  
to NLEC.  
 
Comparison of blood lead levels in VDR polymorphic variants 
in LEBW and NLEC 
Results of BLL for the same set of subjects along 
with their serum vitamin D, calcium and phosphorous 
levels have been analyzed and published by us 
recently as mentioned above. In the present study, the 
association of BLL in LEBW and NLEC groups with 
the VDR gene polymorphic variants and results are 
shown in (Table 4 & Fig. 1). Results show that in the 
occupationally exposed group BLL was significantly 
higher (P ≤ 0.05) in some of the polymorphic variants 
(FF compared to Ff, aa compared to AA and Aa, and 
bbcompared to Bb). Further FF, aa and bbgenotypes 
showed the highest BLL in LEBW study subjects. 
 
Analyses of Serum vitamin D, calcium and phosphorous levels 
in all genotypes of VDR polymorphism variants in LEBW and 
NLEC 
Serum calcium also showed significantly lower 
levels in LEBW for only Ff, TT, Tt, Aa, and Bb 
genotypes whereas phosphorous levels were 
significantly lowered in FF, Ff, TT, Aa, aa, and Bb 
genotypes of LEBW in comparison to NLEC  
(Table 5). Significant differences were not observed 
between different VDR polymorphic variants for 
vitD, Ca and Phosphorus. 
Table 4 — Evaluation of Blood lead levels for all genotypes of VDR gene polymorphic variants (FokI, TaqI, ApaI and BsmI)  
in occupationally exposed lead battery workers (LEBW). Data is expressed as Median (Range).  
Levels of significance is obtained if P <0.05 
Parameters Median (Range)  P -value 
FokI FF (n = 49) Ff (n = 47) ff (n = 4) FF & Ff FF & ff Ff & ff 
BLL (μg/dL) 35.1 
(5.5-139.7) 
21 
(7.7-107.8) 
28.8 
(16.5-58.7) 
< 0.0001 0.45 0.68 
TaqI TT (n = 48) Tt (n = 43) tt (n = 9) TT & Tt TT & tt Tt & tt 
BLL (μg/dL) 31.1 
(14.3-139.7) 
25.4 
(5.5-99) 
28.9 
(10.8-107.8) 
0.08 0.95 0.78 
ApaI AA (n = 32) Aa (n = 35) aa (n = 33) AA & Aa AA & aa Aa & aa 
BLL (μg/dL) 25.6 
(9.9-107.8) 
26.8 
(5.5-105.6) 
37.7 
(14.3-139.7) 
0.99 0.03 0.04 
BsmI BB (n = 21) Bb (n = 43) bb (n = 36) BB & Bb BB & bb Bb & bb 
BLL (μg/dL) 27.9 
(10.8-104.4) 
25.4 
(5.5-107.8) 
37.5 
(14.3-139.7) 
0.99 0.05 0.01 
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Fig. 1 — Box and whiskers plot demonstrating the comparison of Blood lead levels between VDR genes. FF, TT, AA and  
BB represent wild homozygous. Ff, Tt, Aa and Bb represent mutant heterozygous and ff, tt, aa and bb represent mutant homozygous.  
(B) and (C) represent Battery workers and Controls respectively. Within FokI polymorphism difference of BLL between FF and Ff was 
found significant (P <0.0001) amongst LEBW group. TaqI polymorphic variants did not show significant differences between 
themselves. Within ApaI polymorphic variants aa showed significantly different BLL compared to both AA (P =0.03) and Aa (0.04). In 
the BsmI polymorphic variants bb showed significant difference in BLL compared to Bb (P =0.01). The P-value between BB and bb was 
0.05. *= P < 0.05 significant 
 
Table 5 — Serum Vitamin D, Serum calcium and phosphorus levels amongst VDR gene polymorphic variants among  
occupationally lead exposed battery workers (LEBW) and occupationally non-exposed controls (NLEC) 
VDR 
genotypes 
Serum Vitamin D (ng/mL)  Serum calcium (mg/dL)  Serum Phosphorus (mg/dL) 
NLEC 
Mean ± SD 
LEBW 
Mean ± SD 
P -value NLEC 
Mean ± SD 
LEBW 
Mean ± SD 
P -value NLEC 
Mean ± SD 
LEBW 
Mean ± SD 
P -value 
FokI    
FF 53.0 ± 11.6 19.1 ± 8.5 < 0.0001 9.2 ± 0.8 8.8 ± 0.5 0.16 4.1 ± 1.3 3.8 ± 0.9 0.03* 
Ff 55.0 ± 12.5 18.6 ± 9.4 < 0.0001 8.9 ± 0.9 8.8 ± 0.4 <0.0001* 4.3 ± 1.2 3.7 ± 0.8 0.001* 
ff 51.7 ± 11.9 19.3 ± 8.7 ≤ 0.0087 9.5 ± 0.4 8.9 ± 0.4 0.81 4.2 ± 1.3 3.8 ± 1.2 0.64 
TaqI    
TT 52.1 ± 12.6 18.1 ± 7.3 < 0.0001 9.3 ± 0.9 8.7 ± 0.5 0.08 4.1 ± 1.2 3.9 ± 0.8 0.001* 
Tt 54.1 ± 11.0 19.2 ± 10.5 < 0.0001 8.9 ± 0.6 8.9 ± 0.5 <0.0001* 4.2 ± 1.3 3.7 ± 0.9 0.06 
tt 58.2 ± 9.9 21.3 ± 8.7 < 0.0001 9.4 ± 0.8 8.8 ± 0.6 0.11 4.4 ± 1.4 3.4 ± 0.4 0.98 
ApaI    
AA 52.4 ± 12.5 18.7 ± 9.4 < 0.0001 9.2 ± 0.6 8.8 ± 0.5 0.001* 4.2 ± 1.3 3.6 ± 0.7 0.19 
Aa 55.5 ± 10.2 18.7 ± 10.5 < 0.0001 8.8 ± 0.6 8.9 ± 0.5 <0.0001* 4.2 ± 1.3 4.0 ± 0.9 0.005* 
aa 52.3 ± 12.6 19.2 ± 6.6 < 0.0001 9.4 ± 1.1 8.7 ± 0.4 0.22 4.1 ± 1.2 3.7 ± 0.9 0.04* 
BsmI    
BB 55.4 ± 10.3 19.7 ± 8.2 < 0.0001 9.4 ± 0.9 8.7 ± 0.6 0.27 4.2 ± 1.2 3.4 ± 0.8 0.29 
Bb 51.6 ± 12.7 18.8 ± 10.9 < 0.0001 8.9 ± 0.6 8.9 ± 0.5 <0.0001* 4.2 ± 1.3 3.9 ± 0.8 0.008* 
bb 54.3 ± 11.8 18.5 ± 6.5 < 0.0001 8.9 ± 0.9 8.7 ± 0.4 0.25 4.1 ± 1.4 3.9 ± 0.9 0.07 
Data is expressed as mean ± SD. *P <0.05. 
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Regression analysis was performed to study  
the effects of VDR genotypes on BLL and to  
identify the polymorphisms which were independent 
predictors of blood lead levels. Results of univariate 
and multivariate analyses of various characteristics  
is shown in (Table 6). Univariate analysis showed  
that ApaI (aa) and BsmI (bb) genotypes  
had significant association with the BLL in the 
LEBW (P = 0.01 and 0.001, respectively), whereas  
in multivariate analysis with adjustment for age, 
duration of exposure, smoking and alcohol 
consumption we found that genotypes like Ff and bb 
were independently associated with higher blood lead 
level (P <0.05). 
Further, in Table 7, we summarize the different 
genotypic combinations obtained in our LEBW 
subjects along with their mean BLL. Although the 
sample numbers in the different combinations do not 
merit statistical analysis some combinations reveal 
remarkably high or low BLL. 14 samples with 
aa/bb/FF/TT combination showed very high blood 
lead level (82.26 ± 45.32 μg/dL). However, the 
highest BLL (107.8 μg/dL) was observed in one 
sample with AA/Bb/Ff/tt combination. 9 samples with 
Table 6 — Regression analyses to determine associations between demographic characteristics, VDR SNPs,  
clinical parameters and blood lead levels (BLL) in occupationally lead exposed battery workers (LEBW).  
Level of significance is attained if P <0.05. 
Dependent variable BLL (μg/dL) 
Independent variable 
Univariate coefficient  
(95% CI) 
P -value Multivariate coefficient (95% CI) P -value 
Age (yr)     
20-30 ref  Ref  
30-40 −5.6 (−14.7, 3.56) 0.23 -  
40-60 −0.05 (−9.9, 9.75) 0.99 -  
Exposure Status (yr)     
High Exposure (>20) 32.1 (17.1,47.09) 0.001 26.01 (12.7, 39.2) 0.001 
Moderate Exposure (>10-20) 22.7 (8.9, 36.5) 0.001 22.5 (10.34, 34.6) 0.001 
Low  Exposure (<10) ref  Ref  
Smoking Status     
Non smoker ref  Ref  
smoker 17.5 (10.13,24.7) 0.001 -  
Alcohol consumption     
Non drinker ref  Ref  
Drinker 9.9 (2.3, 17.5) 0.01 -  
VDR genotype     
Fok1     
FF ref  Ref  
Ff −5.2 (−13.3, 2.8) 0.20 −12.4 (−18.7, −6.2) 0.001 
ff −3.3 (−24.7, 18.06) 0.76 −25.3 (−53.05, 2.3) 0.07 
Taq1     
TT ref  Ref  
Tt −6.01 (−14.2, 2.03) 0.15 -  
tt −0.77 (−14.8, 13.3) 0.92 9.49 (−1.07, 20.06) 0.07 
Apa1     
AA ref  Ref  
Aa 0.74 (−8.4, 9.8) 0.87 -  
aa 12.4 (2.9, 21.8) 0.01 -  
Bsm1     
BB ref  Ref  
Bb 3.0 (−6.1, 12.07) 0.51 -  
bb 18.7 (8.8, 28.6) 0.001 12.2 (5.49,18.95) 0.001 
Level of significance is attained if P <0.05. 
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Aa/Bb/Ff/tt combination sowed surprisingly low BLL 
(20.28 ± 8.46 μg/dL) than most other combinations. 
 
Discussion 
Apart from multiple modes of exposure ranging 
from inhalation, ingestion, and dermal contact and a 
potential to enter every organ system of our body, 
multiple gene mutations and polymorphisms 
including those in Vitamin D receptors, Amino 
levulenic acid dehydratase (δ-ALAD), glutathione  
S-transferase (GST), and metallothioneins have been 
shown to affect the bioavailability of lead
33-36
. Studies 
have reported that genetic differences among the 
population might sensitize them towards Pb 
exposure
37
. 
This is the first study to report the association of 
vitamin D receptor (VDR) gene polymorphism with 
blood lead levels in occupationally exposed battery 
workers in the Delhi-NCR area. In our previous study, 
we measured BLL, serum vitamin D, calcium and 
phosphorous levels in LEBW and compared them with 
NLEC. In the present study, VDR gene polymorphism 
has been studied along with BLL analysis, Vit D levels, 
and biochemical parameters estimation on the basis of 
different genotypes of each polymorphic variant of the 
VDR gene. Regression analysis was performed to study 
the association between the above parameters and blood 
lead levels in LEBW.  
The SNPs in the VDR gene are known to affect the 
activity of a protein and modify bone mineralization, 
which is regulated by vitamin D and may further 
interact with lead
38
. The genetics and biology of VDR 
polymorphism have been studied previously and the 
effects of different SNPs in the VDR gene have been 
reported. FokI RFLP is reported not to show any 
linkage disequilibrium with other VDR gene 
polymorphism because it is an independent marker of 
the VDR gene. The authors also suggested that the 
FokI allele had some effect on transcription activity. 
On the other hand, BsmI, ApaI, and TaqI RFLPs, 
which are located near the 3UTR have strong linkage 
disequilibrium. These explain associations observed 
with these three VDR RFLPs Bsm1, Apa1 and Taq1 
SNPs regulate the mRNA stability to affect VDR 
gene expression
39
.  
In this study, we found the association of high 
blood lead levels in VDR variants in a setting of 
occupational exposure however, no significant 
association of Taq1 variants with blood lead levels 
(BLL) was observed. In has been reported earlier that 
homozygous mutant (denoted as tt in our study) VDR 
Taq1 genotype had higher lead levels in maternal and 
cord blood in women, however, no statistically 
significant difference was observed
40
.  
In our study, we have also found that aa genotype 
of Apa1 variants had significantly increased blood 
lead levels than those of the other genotypes. The 
finding corroborates with a previous study report that 
Apa1 aa genotype had higher blood lead levels in 
workers and the exposure status, smoking, and 
alcohol drinking are the major factors associated with 
blood lead levels
29
.  
We also found that the FF genotype of the Fok1 
variant had significantly higher BLL than other 
genotypes, which corroborates with the previous 
study reports that VDR Fok1 is an effect modifier of 
the relationship of lead exposure via floor dust and 
blood lead levels
41
. 
Table 7 —  Blood lead levels in occupationally exposed subjects 
with different genotypic combinations of VDR gene 
Genotypic combination n Blood lead level 
(μg/dL) 
AA/BB/FF/Tt 7 32.54 ± 12.17 
AA/BB/FF/tt 4 24.08 ± 8.89 
AA/BB/Ff/TT 1 20.90 
AA/BB/Ff/Tt 4 29.38 ± 21.22 
AA/BB/Ff/tt 3 48.83 ± 48.76 
AA/Bb/FF/Tt 4 30.20 ± 21.46 
AA/Bb/Ff/TT 3 21.43 ± 1.89 
AA/Bb/Ff/Tt 4 21.90 ± 8.24 
AA/Bb/Ff/tt 1 107.8 
AA/bb/FF/TT 1 33.00 
Aa/BB/FF/Tt 1 18.00 
Aa/BB/Ff/tt 1 29.70 
Aa/Bb/FF/TT 3 55.73 ± 43.40 
Aa/Bb/FF/Tt 8 47.46 ± 27.26 
Aa/Bb/Ff/TT 5 23.72 ± 5.61 
Aa/Bb/Ff/tt 9 20.28 ± 8.46 
Aa/Bb/ff/Tt 1 19.8 
Aa/bb/FF/TT 1 36.0 
Aa/bb/FF/Tt 1 78.60 
Aa/bb/Ff/TT 4 24.53 ± 7.91 
aa/Bb/FF/TT 2 24.60 ± 4.67 
aa/Bb/FF/Tt 2 26.10 ± 0.0 
aa/Bb/ff/TT 1 37.80 
aa/bb/FF/TT 14 82.26 ± 45.32 
aa/bb/FF/Tt 1 37.50 
aa/bb/Ff/TT 11 32.35 ± 21.26 
aa/bb/Ff/Tt 1 19.8 
aa/bb/ff/TT 2 37.60 ± 29.84 
Combinations in bold have very high or very low BLL 
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Further, VDR BsmI and TaqI polymorphisms has 
been described in a Polish children cohort to modify 
the relationship between IQ and BLL
27
. The effects of 
VDR SNPs Fok1, Apa1 and Bsm1have been 
demonstrated on blood lead levels among healthy 
pregnant women and are reported having lower lead 
levels with the association of the combination of f, a, 
and b alleles for the VDR Fok1, Apa1, and Bsm1SNPs 
than other VDR haplotypes
26
. Thus, all these studies 
demonstrate the variation of lead accumulation due to 
different VDR polymorphic variants. 
At a molecular level, evidence show that VDR is a 
DNA binding transcription factor of the nuclear 
receptor superfamily
42
. Heterodimerization occurs 
through vitamin D activation with retinoid X receptor 
that is required for DNA binding, nuclear 
translocation, and transcriptional activation or 
suppression
43
. The FokI restriction site is found in 
exon 2 of the VDR gene that causes a change in the 
start codon (a T/C transition polymorphism [ATG to 
ACG]) and results in a VDR protein that binds to 
three amino acids
44
. This can cause altered activity 
and modification of mineral homeostasis and the 
regulation of calcium absorption and regeneration. 
Although the FokI polymorphism is at the NH2 
terminus, where the highly conserved DNA binding 
domain (DBD) is located, the ligand-binding domain 
(LBD) is at the variable COOH-terminus of the VDR 
molecule indicating the independent action of each 
domain
45
. However, LBD and DBD interact 
allosterically to regulate VDR gene expression as the 
FokI region is located in the DBD, it may cause 
changes in molecular mechanisms that ultimately lead 
to biological effects caused by high BLLs
46
. The 
variation in lead absorption may be associated with 
genetic factors that may influence mineral 
metabolism
47
. Because lead is also a bivalent cation; 
like calcium, it competes for absorption and protein-
binding sites, and cellular lead uptake and its 
toxicokinetic scan increase when calcium stores are 
reduced or depleted
48
. 
 
Conclusion  
This study provides insight into the association of 
vitamin D receptor polymorphic variants in 
modulating levels of blood lead (Pb) levels in subjects 
with occupational exposure. In addition, this study 
showed that FokI and BsmI variants are crucial genes 
associated with high BLL and may be suggested as 
potential candidates for genetic screening in industries 
with occupational exposure to lead. The functional 
implications of these genetic variants need to be 
elucidated. 
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